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Background: HIV diagnosis, prognostic and treatment requires T CD4 lymphocytes’ number from flow cytometry,
an expensive technique often not available to people in developing countries. The aim of this work is to apply a
previous developed methodology that predicts T CD4 lymphocytes’ value based on total white blood cell (WBC)
count and lymphocytes count applying sets theory, from information taken from the Complete Blood Count (CBC).
Methods: Sets theory was used to classify into groups named A, B, C and D the number of leucocytes/mm3,
lymphocytes/mm3, and CD4/μL3 subpopulation per flow cytometry of 800 HIV diagnosed patients. Union between
sets A and C, and B and D were assessed, and intersection between both unions was described in order to
establish the belonging percentage to these sets. Results were classified into eight ranges taken by 1000
leucocytes/mm3, calculating the belonging percentage of each range with respect to the whole sample.
Results: Intersection (A ∪ C) ∩ (B ∪ D) showed an effectiveness in the prediction of 81.44% for the range between
4000 and 4999 leukocytes, 91.89% for the range between 3000 and 3999, and 100% for the range below 3000.
Conclusions: Usefulness and clinical applicability of a methodology based on sets theory were confirmed to
predict the T CD4 lymphocytes’ value, beginning with WBC and lymphocytes’ count from CBC. This methodology is
new, objective, and has lower costs than the flow cytometry which is currently considered as Gold Standard.
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HIV infection has affected around 60 million people to
date [1]. In 2009, there were 33.3 million people living
with HIV worldwide; 2.6 million new cases were presented
and 1.8 million deaths were secondary to AIDS in the
same year [2]. By 2009, Sub-Saharan Africa was the lead-
ing region in the world for deaths caused by AIDS, record-
ing 1.3 million cases [2]. Even though AIDS is a global
problem, countries with fewer resources are mostly
affected [2,3].
HIV is a retrovirus that mainly affects T cells and those
cells that express CD4, such as macrophages, follicular
dendritic cells and lymph nodes [4]. In the natural history
of HIV infection, there is an initial decrease in the number
of TCD4 lymphocytes that relates to the clinical primary* Correspondence: grupoinsight2025@yahoo.es
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reproduction in any medium, provided the orinfection (2 weeks after infection); then a partial recovery
occurs, due to atypical lymphocytes and to an increase in
T CD8 lymphocytes (3–4 weeks after exposure). Finally
the number of lymphocytes decreases again; slowly during
the latent period and faster during the final stage which is
characterized by a notorious immunodeficiency with CD4
counts below 500 CD4/μl3 [4]. For this reason, both the
percentage of T CD4 lymphocytes and the occurrence of
opportunistic infections define the stages of HIV infection
and provide treatment guidelines. Currently this percent-
age is one of the referenced biological and immunological
markers for HIV infection and AIDS control and it is also
a predictor of mortality [5]. Its determination is the result
of three laboratory steps: count of WBC, percentage of
WBC that are lymphocytes or differential count, and per-
centage of CD4 lymphocytes. This last stage is performed
by a technique known as “immunophenotyping by flow cy-
tometry”, which consists in the detection of CD4 antigenic
determinants on the surface of WBC using monoclonalral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cedure has several limitations, such as a delay of more than
24 hours between blood collection and its processing, and
the costs of equipment and reagents for flow cytometry,
which make it inaccessible to some developing countries,
especially Africa [5-9].
Given the large impact that HIV/AIDS represent for glo-
bal public health, it has been sought to make flow cytome-
try more accessible by implementing simplified flow
cytometers that are chargeable by battery or solar panels
[8]. On the other hand it has been sought to replace it by
methods of CD4 lymphocytes count prediction from CBC
parameters [10,11], epidemiological variables [12,13] or
machine learning [14]. There is a cross-sectional study of
CD4 prediction from CBC parameters, which used the
combined values of total T lymphocytes and hemoglobin
to deduce CD4 counts <200 cells/μL3; however, when this
prediction was compared to the deduction based on total
lymphocytes, it was found that in male patients sensitivity
increased with no changes in specificity, and in female pa-
tients sensitivity did not change and specificity decreased
[10]. A cross-sectional study that assessed the usefulness
of total lymphocyte count as surrogate marker of T CD4
lymphocyte’s count in HIV-positive patients found that
there is a high correlation [11]. However, low sensitivity of
total lymphocyte count was found in the classification of
patients with CD4 counts <200 cells/μL [11]. Another epi-
demiological study, sought to predict the variability of T
CD4 lymphocytes’ decrease in seropositive patients by de-
termining the distribution of CD4 counts in seronegative
patients and survival rates after acquiring HIV infection
[12]. This model was applied to different populations and
individuals showing accuracy predictions over 75% with
respect to the real value of T CD4 lymphocytes variability
[13]. In the model proposed by Singh and Mars, based on
machine-learning, the CD4 final count is obtained from
the viral load values and the number of weeks after the
first T CD4 lymphocytes’ count, with an accuracy of 83%
with respect to the real value [14].
In a previous study, Rodríguez et al. [15] developed a
new methodology applying sets theory to predict T CD4
lymphocytes’ count based on individual values of total
WBC and lymphocytes obtained from CBCs. In that work
110 CBCs were analyzed and then classified into four sets
named A, B, C and D, where union between sets A and
C and union between sets B and D were evaluated, as well
as the intersection of both unions. These results were
classified into eight ranges of 1,000 leukocytes/mm3
each, for its evaluation. The conclusion was that ranges
below 5000–4000 leukocytes/ml3 predict CD4 counts
lower than 570 CD4/μL3 with effectiveness percentages
between 90-100% [15]. This showed that the study of the
variation process of T CD4 lymphocytes’ count reveals an
underlying mathematical order when observed throughtheoretical abstractions; this order allows making simple
predictions that are independent of virus characteristics or
patient variables.
The aim of this work is to validate the clinical applica-
tion of the methodology developed based on sets theory,
applying it to a larger sample of HIV-positive cases.
Methods
Definitions
Determined Sets for the study of leukocytes/mm3, lym-
phocytes/mm3 and CD4/μL3 populations [15]:
A. {(x,y,z)/x > =6.800 ^ y > =1.800}
B. {(x,y,z)/x > =6.800 ^ z > =300}
C. {(x,y,z)/x < 6.800 ^ y < =2.600}
D. {(x,y,z)/x < 6.800 ^ z < =570}
Where (x, y, z) is a triplet of values, being “x” the num-
ber of WBC, “y” the number of lymphocytes and “z” the T
CD4 lymphocytes’ count.
It is a study in which a physical–mathematical previ-
ously developed methodology based on sets theory is ap-
plied in order to predict T-CD4 lymphocytes’ count. It is
based on the mathematical analysis of the total WBC and
lymphocytes’ count in HIV-positive patients.
Sample
Printed CBCs of 800 HIV diagnosed patients were used,
without distinction of gender, age, population kind, or
clinical variables such as infection stage, hemoglobin value
or medications used. The CBCs were taken from storage
tests in a physical data-base of the infectologist who par-
ticipated in the study.
Procedure
First, records of leukocytes/mm3, lymphocytes/mm3 and
CD4/μL3 subpopulation counts measured by flow cytome-
try were taken. Then, they were organized in descending
order according to the WBC number, establishing ranges
of 1000 leukocytes/mm3. Values higher than 10.000/mm3
were assigned to a single range as well as values lower
than 3.000/mm3, so a total of 9 ranges were established in
order to observe mathematical relationships between pop-
ulations, independent of time or patient’s evolution.
According to the previously developed methodology, re-
cords were evaluated by establishing if they belonged or
not to sets A∪C and B∪D, as well as to set (A∪C) ∩ (B∪D),
using a software that was previously developed based on
sets algebra [15]. This software calculates the range of
values in which the T CD4 lymphocytes’ count is, begin-
ning with WBC and lymphocytes number from CBC and
applying the evaluated predictive methodology.
Results for the 9 leukocytes ranges were assessed, de-
termining the elements number that belong to each set






CD4 A∪C B∪D (A∪C) ∩
(B∪D)
17850 2200 223 X
13180 2160 362 X X X
10000 2480 509 X X X
9920 5060 375 X X X
9570 2960 602 X X X
9000 1920 254 X
8990 3440 472 X X X
8050 850 163
8020 3320 346 X X X
7940 2370 461 X X X
7539 3230 444 X X X
7070 1910 652 X X X
6960 3710 522 X X X
6850 1140 345 X
6000 1290 421 X X X
5870 1080 134 X X X
5600 1770 247 X X X
5200 1800 359 X X X
4999 1680 522 X X X
4510 1570 433 X X X
4070 1680 645 X
3860 1410 396 X X X
3380 1650 20 X X X
3010 1570 109 X X X
2880 1150 54 X X X
2160 1240 110 X X X
1200 684 44 X X X
“X” represents the sample belonging to each assessed set.
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corresponds to, according to the total number found for
each range. In addition, the same values were established
for the whole sample. In this work, the belonging per-
centage of each range to each one of sets is equivalent to
the effectiveness percentage of prediction for such range.
When a triplet of values belongs to all sets, this fact means
that this triplet met with the condition of have a leukocyte
value equal to or higher than 6800/mm3, with a lympho-
cyte value equal to or higher than 1800/mm3 and with a
CD4 cell value equal to or higher than 300/mm3 or it may
have a leukocyte value lesser than 6800/mm3, with a
lymphocyte value equal to or lesser than 2600/mm3 and
with a CD4 cell value equal to or lesser than 570/mm3.
Statistical analysis
Some performance measures were established for each
range through a binary classification performance measure-
ment, where True positive (TP) is the number of cases with
a correct prediction in the range with respect to real values,
False negative (FN) is the number of wrong predictions in
the range with respect to real values, and finally True nega-
tive (TN) is the total number of correct predictions in the
other ranges. The performance measures calculated for
each range were Sensitivity (SENS), and Negative Predictive
Value (NPV); the first one which was calculated with the
next equation:
SENS ¼ TP= TPþ FNð Þ
Otherwise, Negative Predictive Value (NPV) and was
calculated by means of the next equation:
NPV ¼ TN= TNþ FNð Þ
Ethic aspects
This study follows the laws established on articles 11 and
13 of the 008430 Colombia’s Health Ministry resolution of
1993 given that physical calculations were made based on
results of medically prescribed tests of the clinical practice,
from an anonymous database retrospectively evaluated,
with no risks to patients, protecting the integrity and ano-
nymity of participants and with no need of informed con-
sents. The approval of an ethics committee of a specific
institution is not needed because it was accessed only nu-
merical values of the database (without access to the
names, data source or clinic history of patients), collected
specifically for research purposes by one of the authors.
Results
Belonging of leukocytes, lymphocytes and CD4 cells
values to each set in 27 specific samples is shown at the
Table 1. In this table, few examples are shown of each
range and with different belonging states to the definedsets. Namely, particular triplets of values are shown
which do not belong to all the sets, such as the triplet
6850; 1140; 345 which only belong to the B∪D set and
as a consequence it cannot belong to the intersection
set (A ∪ C) ∩ (B ∪ D) . Instead, several triplets of values
are shown which belong to all sets, such as the triplet
2880; 1150; 54 (See Table 1).
Table 2 shows that effectiveness percentage of the predic-
tion for set A ∪ C according to each range, was between
68.42% and 100%, for set B ∪ D was between 65.66% and
100%, and for intersection set (A ∪ C) ∩ (B ∪ D) was be-
tween 55.64% and 100%. Effectiveness percentage of the
prediction for the total number of cases to set A ∪ C was
81%, and to set B∪D was 80%, whereas for total number of
cases to intersection set (A ∪ C) ∩ (B ∪ D) was 73.25% (See
Table 2), being equal or above 73.91% in 6 out of the 9
established ranges, and over 81.44% in 5 ranges. This
Table 2 Elements number (No.) that conform the
established sets according to each range and






A∪C B∪D (A∪C) ∩
(B∪D)
No. % No. % No. %
10000 or more 23 22 95.65 18 78.26 17 73.91
9999 to 9000 42 38 90.48 36 85.71 35 83.33
8999 to 8000 59 56 94.92 48 81.36 49 83.05
7999 to 7000 99 90 90.91 65 65.66 61 61.62
6999 to 6000 133 91 68.42 97 72.93 74 55.64
5999 to 5000 186 159 85.48 149 80.11 129 69.35
4999 to 4000 167 161 96.41 142 85.03 136 81.44
3999 to 3000 74 73 98.65 68 91.89 68 91.89
2999 or less 17 17 100 17 100 17 100
Total 800 707 88 640 80 586 73.25
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D) was higher for the upper and lower ranges; which was
between 83.05% and 83.33% for the ranges of 8000–8999
and 9000–9999, respectively; and was between 81.44% and
91.89% for the ranges of 4000–4999 and 3000–3999, re-
spectively. For the range of leukocytes below 3000, that has
more utility in clinical setting, the effectiveness percentage
was of 100% (See Table 2).Statistical analysis results
TP values ranged between 17 and 136, TN values were be-
tween 450 and 569, and FN between 0 and 59. Values for
SENS ranged between 0.56 and 1, and values for NPV
were between 0.89 and 1. The highest SENS values were
for the ranges of 10000 leukocytes or more, between
9999–9000, 3999–3000, and for the range of 2999 leuko-
cytes or less; the first three had values of 0.99 and the last
one of 1.The NPVs showed values equal to or greater than
0.98 in 5 out of the 9 assessed ranges (See Table 3).Table 3 Values for the statistical analysis made
Ranges of leukocytes TP TN FN SENS NVP
10000 or more 17 569 6 0.74 0.99
9999 to 9000 35 551 7 0.83 0.99
8999 to 8000 49 537 10 0.83 0.98
7999 to 7000 61 525 38 0.62 0.93
6999 to 6000 74 512 59 0.56 0.90
5999 to 5000 129 457 57 0.69 0.89
4999 to 4000 136 450 31 0.81 0.94
3999 to 3000 68 518 6 0.92 0.99
2999 or less 17 569 0 1.00 1.00Discussion
This is the first work in which a new predictive method-
ology of T CD4 lymphocytes’ count is applied to a sample
of 800 HIV-positive patients. This methodology was devel-
oped beginning with the analysis of WBC and lympho-
cytes’ count from CBC, and it is based on sets theory. Its
predictive percentages are equal or above 73.91% for 6 out
of 9 measured ranges, confirming its predictive capacity
and clinical applicability independently of epidemiological
and clinical variables. Sensitivity values over 0.80 were
founding 5 of the 9 measured ranges; specificity was not
calculated, given that there are no False Positives.
Taking into account that the starting of anti-retroviral
treatment is suggested at 300 CD4 cells/cm3, this pre-
dictive methodology showed an effectiveness percentage
of prediction of 100% when leukocyte values were less
than 3000.This means that a value of CD4 less than 570/
mm3 is predicted for all these cases.
The belonging percentage to set A ∪ C is greater than
the percentage to set B ∪ D, showing the specificity of T
CD4 lymphocytes’ values and evidencing the difficulty to
find results that allow their prediction. In contradistinc-
tion to the previous work [15], one more range of leuko-
cytes, from 3999 to 3000, was quantified in this work in
order to study more specifically the ranges of values that
have greater clinical importance. High values in the pre-
dictions were found, with percentages over 73% and
even of 100% for high and low ranges, which are clinic-
ally the most important.
The mathematical theory through which predictions are
obtained does not allow the establishment of False Posi-
tives in the statistical analysis, given that each set, as well
as the intersections that constitute the prediction, exclude
the possibility of finding triplets that allow obtaining a
False Positive prediction. This is the reason why it is not
possible to establish a positive predictive value, showing
that this mathematical inductive way of thinking can’t be
taken directly from traditional statistical parameters; in-
stead of that, the sets algebra way of thinking achieves de-
ductive predictions of clinical importance.
Works performed with the aim to simplify and reduce
costs of HIV patients follow-up are mostly epidemiological,
with limitations in the prediction of immunological bio-
markers [10-13], given that its study from epidemiological
variables or virus characteristics does not allow a complete,
rigorous, objective, and also simple and reproducible ana-
lysis of the immunological response of such patients. Such
is the case of cross-sectional descriptive studies that try to
deduce T CD4 lymphocytes from CBC parameters such as
total lymphocytes’ count or hemoglobin. However, al-
though a correlation between these parameters has been
found, the sensitivity of deductions varies according to gen-
der [10] or to CD4 count itself [11]. Also, studies have
sought to predict the variability of T CD4 lymphocytes’
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bution of CD4 counts in seronegative patients and survival
rates after acquiring HIV infection [12,13]. Other studies
based on machine learning, as the one proposed by Singh
and Mars [14] to obtain the latest CD4 count have an ac-
curacy not greater than 90% and require a previous count
of T CD4 lymphocytes and values of viral load, which rep-
resent a moderate additional cost.
Based on neural networks and machine learning, some
methodologies propose viral load measurement as marker
of treatment response in HIV-infected patients. The limi-
tation of these experimental methodologies is that they
don’t take into account the immune response of the pa-
tient, but genotypic virus characteristics [16-19], which re-
sult in expensive flow cytometry tests [8,9]. In contrast to
these studies, the present study applies a methodology that
uses more accessible data such as the CBC and analyses it
objectively from a sets theory approach in order to deduce
the value of T CD4 lymphocytes with a high success per-
centage. This study provides useful scientific contributions
for the development of control measures and management
of HIV/AIDS pandemic; contributions of clinical applic-
ability that may optimize care and follow-up of patients
that suffer from this disease.
In the context of dynamic systems, a descriptive but
not predictive model of the immune response to HIV
dynamics was developed by plotting how T CD4, CD8,
B lymphocytes and antibodies act, and how the viral
load progresses [20]. The present paper makes an ana-
lysis of the variation process of WBC and lymphocytes
populations in HIV patients, but also allows the predic-
tion of CD4 subtype. Furthermore, since it is based on
a mathematical approach, it does not require statistical
analysis, as it is not required in the study of physical
phenomena such as predicting the trajectory of planets
or an eclipse.
Likewise in this work, where predictions are achieved
from mathematical theories, in different areas of medi-
cine other phenomena have also characterized and pre-
dicted from several mathematical and physical theories,
evidencing the mathematical self-organizations of these
phenomena [21-30].Conclusions
This study confirms the predictive capacity of the devel-
oped methodology based on sets theory to determine the
number of T CD4 cells based on WBC and lymphocytes’
count, achieving a 91.89% effectiveness for the range be-
tween 3000 and 3999 leukocytes, and 100% for the range
below 3000 leukocytes. This methodology can be useful to
determine the number of CD4 in places where there is no
easy access to flow cytometry, reducing costs in determin-
ing the state of patients with HIV/AIDS.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JOR developed the original idea and coordinated the study, SEP and CC
made the data analysis and contributed in drafting and revising the
manuscript; CEP revised the manuscript and made data recollection and its
systematization; JTM and JB revised the manuscript and participated in data
recollection and its systematization; YS and LA contributed in drafting and
revising the manuscript. All authors read and approved the final manuscript.
Acknowledgements
To Universidad Militar Nueva Granada UMNG for its support to this
investigation, especially to Jacqueline Blanco, sub-dean of researches; to Henry
Acuña, chief of the scientific research area; to Martha Bahamón, Academic sub-
dean; to Juan Miguel Estrada, dean of the Faculty of Medicine, and to Esperanza
Fajardo, chief of Investigation Center of Medicine. This study is the result of the
investigation project MED-923, financed by UMNG researches fund.
Dedication
The authors dedicate this work to their children and to all HIV patients in the
world. To Mariana Pajón: for the joy that you gave to Colombia.
Author details
1Insight Group. Research Area and Special Internship “Mathematical and
Physical Theories Applied to Medicine”, Medicine Faculty, Universidad Militar
Nueva Granada, Cr 11 No.101-80 Bogotá, Colombia. 2Medicine Faculty,
Universidad Militar Nueva Granada, Cr 11 No.101-80 Bogotá, Colombia.
Received: 1 October 2012 Accepted: 9 September 2013
Published: 14 September 2013
References
1. Instituto Nacional de Salud: Subdirección de Vigilancia y Control en Salud
Pública. Bogotá: Informe Epidemiológico Nacional 2009 (Colombia); 2010.
2. WHO, UNAIDS: UNAIDS Report on the Global AIDS epidemic 2010. Joint United
Nations Programme on HIV/AIDS. http://www.unaids.org/en/media/unaids/
contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf.
3. Sabogal A, Grupo ITS: Informe de VIH-SIDA Colombia periodo XIII año 2009.
(Colombia). Bogotá: Instituto Nacional de Salud: Subdirección de Vigilancia y
Control en Salud Pública; 2010.
4. Streicher HZ, Reitz MS Jr, Gallo RC: Human Inmunodeficiency viruses. In
Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett
JE, Dolin R. New York: Churchill Livingstone; 2000:1874–87.
5. Brown E, Otieno P, Mbori-Ngacha D, Farquhar C, Obimbo E, Nduati R,
Overbaugh J, John-Stewart GC: Comparison of CD4 Cell Count, Viral Load,
and Other Markers for the Prediction of Mortality among HIV-1–Infected.
J Infect Dis 2009, 199(9):1292–1300.
6. Centers for Disease Control and Prevention: 1997 Revised Guidelines for
Performing CD4+ T-Cell Determinations in Persons Infected with Human
Immunodeficiency Virus. http://wwwn.cdc.gov/mpep/pdf/tli/rr4602.pdf.
7. Mandy F, Nicholson J, McDougal JS: Guidelines for Performing Single-Platform
Absolute CD4+ T-Cell Determinations with CD45 Gating for Persons Infected
with Human imunodeficiency Virus. http://www.cdc.gov/mmwr/preview/
mmwrhtml/rr5202a1.htm.
8. Zijenah L, Kadzirange G, Madzime S, Borok M, Mudiwa C, Tobaiwa O,
Mucheche M, Rusakaniko S, Katzenstein DA: Affordable flow cytometry for
enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1
infected adults requiring antiretroviral therapy (ART) and monitoring
response to ART in a resource-limited setting. J Transl Med 2006, 4:33.
9. Imade GI, Badung B, Pam S, Agbaji O, Egah D, Sagay AS, Sankalé JL, Kapiga
S, Idoko J, Kanki P: Comparison of a new, affordable flow cytometric
method and the manual magnetic bead technique technique for CD4
T-lymphocyte countining in a Northern Nigeria Setting. Clin Diag Lab
Immunol 2005, 12:224–227.
10. Budiono W: Total lymphocyte count and hemoglobin combined to
predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/
AIDS. Acta Med Indones 2008, 40(2):59–62.
11. Gitura B, Joshi MD, Lule GN, Anzala O: Total lymphocyte count as a
surrogate marker for CD4+ t cell count in initiating antiretroviral therapy
at Kenyatta National Hospital. Nairobi East Afr Med J 2007, 84(10):466–72.
Rodríguez et al. BMC Medical Physics 2013, 13:3 Page 6 of 6
http://www.biomedcentral.com/1756-6649/13/312. Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, Dye C: HIV
Infection, Antiretroviral Therapy, and CD4+ Cell Count Distributions in
African Populations. J Infect Dis 2006, 194:1450–8.
13. Williams BG, Korenromp EL, Gouws E, Dye C: The rate of decline of CD4 T-cells in
people infected with HIV. http://arxiv.org/ftp/arxiv/papers/0908/0908.1556.pdf.
14. Singh Y, Mars M: Support vector machines to forecast changes in CD4
count of HIV-1 positive patients. Sci Res Essay 2010, 5(17):2384–2390.
15. Rodríguez J, Prieto S, Bernal P, Pérez C, Correa C, Vitery S: Teoría de
conjuntos aplicada a poblaciones de leucocitos, linfocitos y CD4 de
pacientes con VIH. Predicción de linfocitos T CD4, de aplicación clínica.
Rev Fac Med 2011, 19(2):148–156.
16. Larder B, Wang D, Revell A, Montaner J, Harrigan R, De Wolf F, Lange J, Wegner
S, Ruiz L, Pérez-Elías MJ, Emery S, Gatell J, Monforte AD, Torti C, Zazzi M, Lane C:
The development of artificial neural networks to predict virological
response to combination HIV therapy. Antivir Ther 2007, 12(1):15–24.
17. Altman A, Däumer M, Beerenwinkel N, Peres Y, Schülter E, Büch J, et al:
Predicting the Response to Combination Antiretroviral Therapy:
Retrospective Validation of geno2pheno-THEO on a Large Clinical
Database. JID 2009, 199:999–1006.
18. Altmann A, Rosen-Zvi M, Prosperi M, Aharoni E, Neuvirth N, Schülter E, Büch
J, Struck D, Peres Y, Incardona F, Sönnerborg A, Kaiser R, Zazzi M, Lengauer
T: Comparison of Classifier Fusion Methods for Predicting Response to
Anti HIV-1 Therapy. PLoS ONE 2008, 3(10):e3470.
19. Wang D, DeGruttola V, Hammer S, Harrigan R, Larder B, Wegner S, Winslow
D, Zazzi M: A Collaborative HIV Resistance Response Database Initiative:
Predicting Virological Response Using Neural Network Models (Poster
presentation). Seville: A Collaborative HIV Resistance Response Database
Initiative: Predicting Virological Response Using Neural Network Models
(Poster presentation). XI International HIV Drug Resistance Workshop; 2002.
http://www.hivrdi.org/abstract_3.htm.
20. Vélez N, Torrealdea J: Modelado en dinámica de sistemas de la respuesta
inmune ante la infección del VIH-1. Ini Inv 2006, 1:1–9.
21. Rodríguez J: Diferenciación matemática de péptidos de alta unión de
MSP-1 mediante la aplicación de la teoría de conjuntos. Inmunología
2008, 27(2):63–68.
22. Rodríguez J: Teoría de conjuntos aplicada a la caracterización matemática
de unión de péptidos al HLA clase II. Rev Cienc Salud 2008, 6(1):9–15.
23. Rodríguez J: Teoría de unión al HLA clase II teorías de Probabilidad
Combinatoria y Entropía aplicadas a secuencias peptídicas.
Inmunología 2008, 27(4):151–166.
24. Rodríguez J, Bernal P, Prieto S, Correa C: Teoría de péptidos de alta unión
de malaria al glóbulo rojo. Predicciones teóricas de nuevos péptidos de
unión y mutaciones teóricas predictivas de aminoácidos críticos.
Inmunología 2010, 29(1):7–19.
25. Rodríguez J: Entropía Proporcional De Los Sistemas Dinámicos Cardiacos:
Predicciones físicas y matemáticas de la dinámica cardiaca de aplicación
clínica. Rev Colomb Cardiol 2010, 17:115–129.
26. Rodríguez J, Prieto S, Melo M, Domínguez D, Correa C, Soracipa Y, Forero M,
Seoane R, Tapia D, Ramírez S: Entropía proporcional de la dinámica
cardiaca aplicada al diagnóstico de pacientes de la Unidad de Cuidados
Intensivos. Medicina 2013, 35(100):17–28.
27. Rodríguez J: Mathematical law of chaotic cardiac dynamic: Predictions of
clinic application. J Med Med Sci 2011, 2(8):1050–1059.
28. Rodriguez J, Prieto S, Correa C, Bernal P, Puerta G, Vitery S, Soracipa Y,
Muñoz D: Theoretical generalization of normal and sick coronary arteries
with fractal dimensions and the arterial intrinsic mathematical harmony.
BMC Med Phys 2010, 10:1–6.
29. Rodríguez J, Prieto S, Correa C, Posso H, Bernal P, Puerta G, Vitery S, Rojas I:
Generalización Fractal de Células Preneoplásicas y Cancerígenas del
Epitelio Escamoso Cervical. Una Nueva Metodología de Aplicación
Clínica. Rev Fac Med 2010, 18(2):173–181.
30. Rodríguez J: Método para la predicción de la dinámica temporal de la malaria
en los municipios de Colombia. Rev Panam Salud Publica 2010, 27(3):211–218.
doi:10.1186/1756-6649-13-3
Cite this article as: Rodríguez et al.: Predictions of CD4 lymphocytes’
count in HIV patients from complete blood count. BMC Medical Physics
2013 13:3.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
